Martin Mickey M, Buckenberger Jessica A, Knoell Daren L, Strauch Arthur R, Elton Terry S
College of Pharmacy, Division of Pharmacology, The Ohio State University, Columbus, OH 43210, USA.
Mol Cell Endocrinol. 2006 Apr 25;249(1-2):21-31. doi: 10.1016/j.mce.2006.01.009. Epub 2006 Feb 28.
At least four alternatively spliced mRNAs can be synthesized from the human AT(1)R (hAT(1)R) gene that differ only in the inclusion or exclusion of exon 2 and/or 3. RT-PCR experiments demonstrate that splice variants harboring exon 2 accounts for at least 30% of all the hAT(1)R mRNA transcripts expressed in the human tissues investigated. Since exon 2 contains two upstream AUGs or open reading frames (uORFs), we hypothesized that these AUGs would inhibit the translation of the downstream hAT(1)R protein ORF harbored in exon 4. This study demonstrates that the inclusion of exon 2 in hAT(1)R mRNA transcripts dramatically reduces hAT(1)R protein levels (nine-fold) and significantly attenuates Ang II responsiveness ( approximately four-fold). Interestingly, only when both AUGs were mutated in combination were the hAT(1)R density and Ang II signaling levels comparable with those values obtained using mRNA splice variants that did not include exon 2. This observation is consistent with a model where the majority of the ribosomes likely translate uORF#1 and are then unable to reinitiate at the downstream hAT(1)R ORF, in part due to the presence of AUG#2 and to the short intercistronic spacing. Importantly, TGF-beta(1) treatment (4ng/ml for 4h) of fibroblasts up-regulated hAT(1)R mRNA splice variants, which harbored exon 2, six-fold. Since AT(1)R activation is closely associated with cardiovascular disease, the inclusion of exon 2 by alternative splicing represents a novel mechanism to reduce the overall production of the hAT(1)R protein and possibly limit the potential pathological effects of AT(1)R activation.
人类血管紧张素Ⅱ1型受体(hAT(1)R)基因可合成至少四种选择性剪接的mRNA,它们之间的差异仅在于外显子2和/或外显子3的包含或缺失。逆转录聚合酶链反应(RT-PCR)实验表明,含有外显子2的剪接变体占所研究人体组织中表达的所有hAT(1)R mRNA转录本的至少30%。由于外显子2包含两个上游AUG(或开放阅读框,uORF),我们推测这些AUG会抑制外显子4中所含下游hAT(1)R蛋白开放阅读框的翻译。本研究表明,hAT(1)R mRNA转录本中包含外显子2会显著降低hAT(1)R蛋白水平(降低九倍),并显著减弱血管紧张素Ⅱ反应性(约四倍)。有趣的是,只有当两个AUG同时发生突变时,hAT(1)R密度和血管紧张素Ⅱ信号水平才与使用不包含外显子2的mRNA剪接变体所获得的值相当。这一观察结果与一种模型一致,即大多数核糖体可能翻译uORF#1,然后无法在下游hAT(1)R开放阅读框处重新起始翻译,部分原因是存在AUG#2以及短的顺反子间间距。重要的是,用转化生长因子-β1(TGF-β1,4ng/ml处理4小时)处理成纤维细胞可使含有外显子2的hAT(1)R mRNA剪接变体上调六倍。由于AT(1)R激活与心血管疾病密切相关,通过选择性剪接包含外显子2代表了一种新机制,可减少hAT(1)R蛋白的总体产生,并可能限制AT(1)R激活的潜在病理效应。